LEADER 02215oam  2200589   450 
001 9910707013003321
005 20160404165636.0
035   $a(CKB)5470000002461362
035   $a(OCoLC)52632190$z(OCoLC)53237077
035   $a(EXLCZ)995470000002461362
100   $a20030717d2002      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNIAID biodefense research agenda for CDC category A agents
210  1$a[Bethesda, Md.] :$cU.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases,$d2002.
215   $a1 online resource (v, 37, A-12 pages)
225 1 $aNIH publication ;$vno. 03-5308
300   $aTitle from PDF title screen (viewed on July 17, 2003).
300   $a"NIAID biodefense, preparing through research."
300   $a"February 2002."
517 1 $aNational Institute of Allergy and Infectious Diseases biodefense research agenda for CDC category A agents
517 3 $aBiodefense research agenda for CDC category A agents
606   $aPathogenic microorganisms$xResearch$zUnited States
606   $aBiological decontamination$xResearch$zUnited States
606   $aBioterrorism$zUnited States$xPrevention
606   $aBioterrorism$xprevention & control
606   $aBiological Warfare$xprevention & control
606   $aCommunicable Disease Control
607   $aUnited States
615  0$aPathogenic microorganisms$xResearch
615  0$aBiological decontamination$xResearch
615  0$aBioterrorism$xPrevention.
615 12$aBioterrorism$xprevention & control.
615 22$aBiological Warfare$xprevention & control.
615 22$aCommunicable Disease Control.
712 02$aNational Institute of Allergy and Infectious Diseases (U.S.),
801  0$bNLM
801  1$bNLM
801  2$bGPO
801  2$bJTB
801  2$bCGC
801  2$bSYB
801  2$bOCLCQ
801  2$bOCLCO
801  2$bGPO
906   $aBOOK
912   $a9910707013003321
996   $aNIAID biodefense research agenda for CDC category A agents$93292129
997   $aUNINA